LK

Lily Kwatra

Active Director Director DIN 09595769
DIN 09595769 First appointment Jan 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Lily Kwatra

Data last updated:

Lily Kwatra is a Director at Optimus Research Labs Private Limited (since 2025). The company operates in Healthcare. Optimus Research Labs Private Limited reported revenue of ₹18,900 (FY 2022).

DIN 09595769
Primary Designation Director
Industry Healthcare
First Appointment 10 Jan 2025
Oldest Company Age 13 yrs
Largest company Optimus Research Labs Private Limited · ₹18,900 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jan 20252013₹18,900 (FY 2022)Active

Board colleagues of Lily Kwatra

NameDINCompanyDesignation
Karuna Gandharva09595768Optimus Research Labs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Optimus Research Labs Private Limited
Premium access

Shareholding and investment profile for Lily Kwatra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lily Kwatra

Lily Kwatra currently holds 1 directorship: Optimus Research Labs Private Limited (Director, since 10 Jan 2025, revenue ₹18,900 (FY 2022)).

Lily Kwatra was first appointed on 10 Jan 2025 as Director at Optimus Research Labs Private Limited.

The current boards of Lily Kwatra's companies include Karuna Gandharva (Optimus Research Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available